NCT00330759 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 890
- group Id
- BG001
- value
- 886
- group Id
- BG002
- value
- 1776
- units
- Participants
- groups
- description
- Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks
- id
- BG000
- title
- Zoledronic Acid
- description
- Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.7
- value
- 60.6
- group Id
- BG001
- spread
- 11.4
- value
- 59.3
- group Id
- BG002
- spread
- 11.1
- value
- 59.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 338
- group Id
- BG001
- value
- 298
- group Id
- BG002
- value
- 636
- title
- Female
- measurements
- group Id
- BG000
- value
- 552
- group Id
- BG001
- value
- 588
- group Id
- BG002
- value
- 1140
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 770
- group Id
- BG001
- value
- 770
- group Id
- BG002
- value
- 1540
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 49
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 85
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 80
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 179
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 452
- group Id
- BG001
- value
- 457
- group Id
- BG002
- value
- 909
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 345
- group Id
- BG001
- value
- 343
- group Id
- BG002
- value
- 688
- title
- Non-small cell lung cancer
- param Type
- NUMBER
- title
- Tumor Type Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 446
- group Id
- BG001
- value
- 440
- group Id
- BG002
- value
- 886
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 444
- group Id
- BG001
- value
- 446
- group Id
- BG002
- value
- 890
- title
- No
- param Type
- NUMBER
- title
- Previous Skeletal-Related Event Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 747
- group Id
- BG001
- value
- 746
- group Id
- BG002
- value
- 1493
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 143
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 283
- title
- No
- param Type
- NUMBER
- title
- Systematic Anti-Cancer Therapy Stratification Factor
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 890
- group Id
- BG001
- value
- 886
- group Id
- BG002
- value
- 1776
- units
- Participants
- groups
- description
- Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks
- id
- BG000
- title
- Zoledronic Acid
- description
- Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks
- id
- BG001
- title
- Denosumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.7
- value
- 60.6
- group Id
- BG001
- spread
- 11.4
- value
- 59.3
- group Id
- BG002
- spread
- 11.1
- value
- 59.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 338
- group Id
- BG001
- value
- 298
- group Id
- BG002
- value
- 636
- title
- Female
- measurements
- group Id
- BG000
- value
- 552
- group Id
- BG001
- value
- 588
- group Id
- BG002
- value
- 1140
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 770
- group Id
- BG001
- value
- 770
- group Id
- BG002
- value
- 1540
- title
- White or Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 49
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 85
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 80
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Japanese
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 16
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 93
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 179
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 452
- group Id
- BG001
- value
- 457
- group Id
- BG002
- value
- 909
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 345
- group Id
- BG001
- value
- 343
- group Id
- BG002
- value
- 688
- title
- Non-small cell lung cancer
- param Type
- NUMBER
- title
- Tumor Type Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 446
- group Id
- BG001
- value
- 440
- group Id
- BG002
- value
- 886
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 444
- group Id
- BG001
- value
- 446
- group Id
- BG002
- value
- 890
- title
- No
- param Type
- NUMBER
- title
- Previous Skeletal-Related Event Stratification Factor
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 747
- group Id
- BG001
- value
- 746
- group Id
- BG002
- value
- 1493
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 143
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 283
- title
- No
- param Type
- NUMBER
- title
- Systematic Anti-Cancer Therapy Stratification Factor
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle